Trending Articles

  1. Panthera expands Glasgow clinical research capacity with new centre at Health Innovation Hub Purpose-built facility will support Phase II and III trials and broaden participation across Glasgow and the west of Scotland
  2. Samplix secures backing to accelerate Xdrop’s commercial expansion in antibody discovery WLan-led financing reaches a €25m first closing, comprising €3m in new capital and €22m in shareholder convertible-bond conversions
  3. Lonza upgrades organic growth model and mid-term financial ambitions at capital Markets Day; Q3 2026 in line with expectations At its Capital Markets Day in Vacaville, California, Lonza reports progress of its One Lonza Strategy to deliver long-term, profitable, above-market growth
  4. Adalvo expands biosimilars portfolio with Romiplostim programme acquisition from Enzene Acquisition accelerates Adalvo’s expansion into complex biologics and strengthens its biosimilars portfolio across development and commercialisation
  5. LGM Pharma acquires Sannova Analytical to expand pharma testing services The acquisition adds GLP bioanalysis, nitrosamine impurity testing and extractables and leachables services to LGM Pharma’s pharmaceutical testing capabilities

You may also like

Manufacturing Alcami, a leading contract development and manufacturing organisation (CDMO), today announced its strengthening of laboratory leadership with the promotion of Robert Tragas to...
Alcami Announces promotion of Robert Tragas to Vice President, Laboratory Services

Alcami Announces promotion of Robert Tragas to Vice President, Laboratory Services

Read more
Manufacturing Expansion strengthens Codis’ UK pathway from formulation development through to commercial-scale manufacturing
Codis completes demolition and begins construction on PSD-4 expansion at Haverhill

Codis completes demolition and begins construction on PSD-4 expansion at Haverhill

Read more
Finance Purpose-built facility will support Phase II and III trials and broaden participation across Glasgow and the west of Scotland
Panthera expands Glasgow clinical research capacity with new centre at Health Innovation Hub

Panthera expands Glasgow clinical research capacity with new centre at Health Innovation Hub

Read more
Finance Acquisition accelerates Adalvo’s expansion into complex biologics and strengthens its biosimilars portfolio across development and commercialisation
Adalvo expands biosimilars portfolio with Romiplostim programme acquisition from Enzene

Adalvo expands biosimilars portfolio with Romiplostim programme acquisition from Enzene

Read more
Finance WLan-led financing reaches a €25m first closing, comprising €3m in new capital and €22m in shareholder convertible-bond conversions
Samplix secures backing to accelerate Xdrop’s commercial expansion in antibody discovery

Samplix secures backing to accelerate Xdrop’s commercial expansion in antibody discovery

Read more
Packaging Recipharm expands its sterile manufacturing capacity with a new cream and ointment line at Odivelas, Portugal, which is able to produce 8–15 million units per year
More tubes, more choice: Recipharm expands sterile creams and ointments

More tubes, more choice: Recipharm expands sterile creams and ointments

Read more
Finance The acquisition adds GLP bioanalysis, nitrosamine impurity testing and extractables and leachables services to LGM Pharma’s pharmaceutical testing capabilities
LGM Pharma acquires Sannova Analytical to expand pharma testing services

LGM Pharma acquires Sannova Analytical to expand pharma testing services

Read more
Manufacturing Vetter’s Ayse Hizli discusses commercial supply chain planning, digital visibility, resilience and cold-chain management from clinical development to market launch
Streamlining supply chains from clinical trial to commercial scale

Streamlining supply chains from clinical trial to commercial scale

Read more
Manufacturing At its Capital Markets Day in Vacaville, California, Lonza reports progress of its One Lonza Strategy to deliver long-term, profitable, above-market growth
Lonza upgrades organic growth model and mid-term financial ambitions at capital Markets Day; Q3 2026 in line with expectations

Lonza upgrades organic growth model and mid-term financial ambitions at capital Markets Day; Q3 2026 in line with expectations

Read more
Finance The acquisition will add a Phase III-ready siRNA therapy for polycythaemia vera to Merck’s rare disease pipeline, strengthening the German group’s precision medicine strategy
Merck to acquire Silence Therapeutics in $1.3bn RNA deal

Merck to acquire Silence Therapeutics in $1.3bn RNA deal

Read more
Manufacturing Company increases its score to 82 out of 100 points, ranking in the top 5% of rated companies and the top 1% for sustainable procurement
Gerresheimer improves EcoVadis rating and retains Gold status

Gerresheimer improves EcoVadis rating and retains Gold status

Read more
Manufacturing Experienced CRO leader brings deep scientific, commercial and operational expertise to lead the company’s next phase of growth
Concept Life Sciences appoints Dr Adrijana Vinter as Chief Executive Officer

Concept Life Sciences appoints Dr Adrijana Vinter as Chief Executive Officer

Read more
Finance The Parsortix platform harvests CTCs from blood and can be integrated with existing laboratory instruments for comprehensive downstream analysis
CellBxHealth signs new statement of work with US-based pharmaceutical company

CellBxHealth signs new statement of work with US-based pharmaceutical company

Read more
Finance The purchase strengthens Malvern Panalytical’s biopharmaceutical characterisation capabilities, building on the development of its high-throughput Zetasizer Core stability...
Malvern Panalytical acquires Dimer Instruments to expand biopharma analysis

Malvern Panalytical acquires Dimer Instruments to expand biopharma analysis

Read more
Finance The company has agreed to acquire New York-based Kinentia Biosciences, expanding its US presence and combining Kinentia’s early-stage development expertise with Ofichem’s...
Ofichem acquires US drug substance CDMO Kinentia Biosciences to expand transatlantic network

Ofichem acquires US drug substance CDMO Kinentia Biosciences to expand transatlantic network

Read more
Finance Piramal Pharma Solutions (PPS) is to invest more than $5.3m in upgrading its drug substance manufacturing site in Aurora, Canada, supported by a $1.75m investment from the...
Piramal Pharma receives Ontario investment for API site

Piramal Pharma receives Ontario investment for API site

Read more